In cancer cells, ERK5 either promotes or inhibits SNAIL function (Marchetti et al., 2008; Xu et al., 2021), although ERK5 activation usually promotes EMT by increasing the function of SLUG, ZEB1, and ZEB2 (Arnoux et al., 2008; Antoon et al., 2013a). Here, ZEB1 is linked to cancer.